维普中文期刊产品整合服务
12篇 您的检索式:作者名="Pinget M"
    题名 作者 年代 出处 被引量
1Physiological basis of insulin secretion abnormalities显示文摘Pinget M Boullu-Sanchis S 2002Diabetes Metab2002,28,6:1
2Cholecystokinin octapoptide: a potential growth factor for pancreatic beta cells in diabetic rats 显示文摘Kuntz E Pinget M Damge P 2004JOP2004,5,:1
3Effects of cholecystokinin oc- tapeptide on the exocrine pancreas in a new rat model of type 2 di- abetes 显示文摘KUNTZ E PINGET M DAMGIC 2002Eur J Pharmacol2002,448,23:1
4Cholecystokinin octapeptide:a potential grow-th factor for pancreatic beta cells in diabetic rats显示文摘Kuntz E Pinget M Damge P 2004JOP2004,5,6:1
5Prolactinomas express human heparinbinding secretory transformation gene (hst) protein product: marker oftumor invasiveness显示文摘 Pinget M Kessler 1 1998Clin Endocrinol Oxf1998,48,:1
6Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain: 52-week data from the PREDICTIVE study in a cohort of French patients with type 1 or type 2 diabetes显示文摘Matte M Pinget M Gin H etal 2009Diabetes Metab2009,35,6:1
7Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain:52-week data from the PREDICTIVETM study in a cohort of French patients with type 1 or type 2 diabetes显示文摘Marre M Pinget M Gin H 2009Diabetes Metab2009,35,6:1
8Cholecystokinin octapeptide: a potential growth factor for pancreatic beta cells in diabetic rats 显示文摘Kuntz E Pinget M Damge P 2004JOP2004,5,6:1
9Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain:52-week data from the PREDICTIVE study in a cohort of French patients with type 1 or type 2 diabetes显示文摘MARRE M PINGET M GIN H 2009Diabetes Metab2009,35,6:1
10Cholecystokinin octapeptide:a potential growth factor for pancreatic beta cells in diabetic rats显示文摘Kuntz E Pinget M Damge P 2004JOP2004,5,6:1
11Effi- cacy and safety of lixisenatide once daily versus pla- cebo in type 2 diabetes insufficiently controlled on pioglitazone (GetGoal-P)显示文摘Pinget M Goldenberg R Niemoeller E 2013Diabetes Obes Metab2013,15,11:1
12Effect of insulin detemir dose frequency on clinical outcomes in patients with diabetes in PREDICTIVE 显示文摘Fontaine P Gin H Pinget M 2009Adv Ther2009,26,5:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费